Autopsy report · NCT05039931

A Study of GNC-035, a Tetra-specific Antibody, in Participants With Locally Advanced or Metastatic Solid Tumors

“leading entity of the clinical trial was replaced, and no patients were enrolled.”

The sponsor’s own words in the registry.

Life of this trial

• Withdrawn before it enrolled anyone. Its dates are the sponsor's plans, not events that happened.

Vital statistics

Status

Withdrawn

Phase

Phase 1

Sponsor

Sichuan Baili Pharmaceutical Co., Ltd.

Sponsor type

Industry

Conditions

Breast Cancer; Solid Tumor

Interventions

GNC-035

Participants

0

Sites

1

Countries

China

Trials that died the same way

• Detection of Diffuse Scar in Patients With Diabetes
  “No participants were enrolled in the trial.” (81% match in meaning)
• Detection of Prostate Cancer With Non-invasive Method Based on DNA Methylation of Circulated Tumor DNA, PBMC
  “No participants enrolled, leading to insufficient patient numbers to initiate the clinical trial.” (81% match in meaning)
• Use of the INAMED LAPBAND System to Reduce BMI's in Obese Renal Failure Patients
  “No patients were enrolled.” (80% match in meaning)
• Tolerability, Safety and Activity of a Muscle Relaxant Molecule IDN5243 in Patients With Low Back Pain
  “No patients enrolled in the study.” (78% match in meaning)
• Recombinant Human Thrombopoietin (rhTPO) Combining Rituximab Versus High-dose Dexamethasone for Initial Treatment of Primary Immune Thrombocytopenia (ITP)
  “No eligible patient was enrolled.” (78% match in meaning)

Look deeper

• The official registry record (the source of truth)
• Record history: every change the sponsor made
• Open it in the database

Everything here comes from the current ClinicalTrials.gov record. The timeline uses the record’s dates; dates marked planned are the sponsor’s plans. The cause of death is an automatic, unverified label. This is research information, not medical advice.